Clinical Trials for Prelude Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Prelude Therapeutics

Clinical Trials (3)

NCT06682806
A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
PHASE2Active, not recruiting
7 participants
Started: Jun 3, 2025 · Completed: Dec 31, 2027
5 conditions2 sponsors9 locations
NCT06560645
A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
PHASE1Recruiting
104 participants
Started: Nov 4, 2024 · Completed: Apr 30, 2027
10 conditions1 sponsor28 locations
NCT05665530
A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies
PHASE1Active, not recruiting
86 participants
Started: Sep 12, 2023 · Completed: Mar 31, 2026
12 conditions2 sponsors24 locations